HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Union For Ethical BioTrade Invites Comment On Draft Standard

This article was originally published in The Rose Sheet

Executive Summary

The Union for Ethical BioTrade is soliciting comment on proposed changes to its Ethical BioTrade Standard based on input from stakeholders, including the broadening of its scope to cover all natural ingredients rather than merely “native” natural ingredients.

You may also be interested in...

Consumers Cloudy On Biodiversity Issue As Movement Grows Across Globe

Consumers around the world are growing increasingly familiar with the term “biodiversity,” but that doesn’t mean they know what it is.

Global Biodiversity Pact’s Potential Impact On Personal Care Still Unclear

Six months after the adoption of the Nagoya Protocol – an international treaty conceived to help ensure fairness in the way genetic resources are mined for research and development purposes – the extent to which the personal-care industry will be impacted is still not entirely clear.

Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies

Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts